Ipca Laboratories Limited

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949.

When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti.

For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments.

Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others.

– One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally
– 15 APIs & 11 Formulations manufacturing facility across the globe
Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis
– Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy
– 4 formulations rank amongst the top 300 brands of IPM as per IQVIA

Company’s Keywords:

manufacturing, marketing of formulations, active pharmaceutical ingredients, crams, exports to us, eu, other emerging markets, antimalarials, disease modifying antirheumatic drugs, pain management, rheumatology, gastrointestinal, cardiovascular, antidiabetics, cough, cold, neuropsychiatry, dermatology, antibiotics, urology, nutraceuticals, cosmoceuticals, opthalmology, apis, generics, formulations, pharmaceuticals & active pharmaceutical ingredients